Page last updated: 2024-08-21

benzoxazoles and Amyloid Neuropathies

benzoxazoles has been researched along with Amyloid Neuropathies in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Le, VH; Lockwood, PA; O'Gorman, MT; Patterson, TA; Riley, S; Sultan, MB; Tankisheva, E; Wang, Q1
Amass, L; Gundapaneni, BK; Keohane, DJ; Li, H; Schwartz, JH1
Buxbaum, JN1
Aimo, A; Barison, A; Castiglione, V; Emdin, M; Fontana, M; Giannoni, A; Merlini, G; Passino, C; Perfetto, F; Rapezzi, C; Seferović, PM; Vergaro, G1
Adams, D; Algalarrondo, V; Cauquil, C; Rousseau, A; Slama, MS; Theaudin, M1
Grippon, S; Kirkpatrick, P; Said, G1

Reviews

3 review(s) available for benzoxazoles and Amyloid Neuropathies

ArticleYear
Treatment of hereditary and acquired forms of transthyretin amyloidosis in the era of personalized medicine: the role of randomized controlled trials.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2019, Volume: 26, Issue:2

    Topics: Amyloid Neuropathies; Amyloid Neuropathies, Familial; Benzoxazoles; Diflunisal; Female; Humans; Male; Oligonucleotides; Prealbumin; Precision Medicine; Randomized Controlled Trials as Topic; RNA, Small Interfering; Treatment Outcome

2019
Treatment of cardiac transthyretin amyloidosis: an update.
    European heart journal, 2019, 12-01, Volume: 40, Issue:45

    Topics: Amyloid; Amyloid Neuropathies; Amyloid Neuropathies, Familial; Benzoxazoles; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Heart Failure; Heart Transplantation; Humans; Liver Transplantation; Mutation; Oligonucleotides; Prealbumin; RNA, Small Interfering; Stroke Volume

2019
Current and future treatment of amyloid neuropathies.
    Expert review of neurotherapeutics, 2014, Volume: 14, Issue:12

    Topics: Amyloid Neuropathies; Animals; Benzoxazoles; Genetic Therapy; Humans; Liver Transplantation; Mutation; Prealbumin

2014

Trials

2 trial(s) available for benzoxazoles and Amyloid Neuropathies

ArticleYear
The Bioequivalence of Tafamidis 61-mg Free Acid Capsules and Tafamidis Meglumine 4 × 20-mg Capsules in Healthy Volunteers.
    Clinical pharmacology in drug development, 2020, Volume: 9, Issue:7

    Topics: Administration, Oral; Adult; Amyloid Neuropathies; Amyloid Neuropathies, Familial; Benzoxazoles; Brazil; Canada; Cardiomyopathies; Cross-Over Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Compounding; Fasting; Female; Healthy Volunteers; Humans; Japan; Male; Middle Aged; Prealbumin; Safety; Therapeutic Equivalency; United States

2020
Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy.
    Orphanet journal of rare diseases, 2018, 12-17, Volume: 13, Issue:1

    Topics: Adult; Amyloid Neuropathies; Amyloidosis; Benzoxazoles; Disease Progression; Double-Blind Method; Female; Humans; Male; Middle Aged; Prealbumin; Prospective Studies

2018

Other Studies

1 other study(ies) available for benzoxazoles and Amyloid Neuropathies

ArticleYear
Tafamidis.
    Nature reviews. Drug discovery, 2012, Mar-01, Volume: 11, Issue:3

    Topics: Amyloid Neuropathies; Animals; Benzoxazoles; Clinical Trials as Topic; Humans; Prealbumin

2012